Examination of effect of yokukansan in prevention of the delirium after the surgical operation.
Phase of Trial: Phase II
Latest Information Update: 21 Jan 2017
At a glance
- Drugs TJ 54 (Primary)
- Indications Delirium
- Focus Adverse reactions; Therapeutic Use
- 21 Jan 2017 Primary endpoint (Postoperative delirium incidence) has not been met.
- 21 Jan 2017 Results presented at the 2017 Gastrointestinal Cancers Symposium
- 01 Jun 2016 Status changed from active, no longer recruiting to completed.